C9ORF72‐ALS: P62‐ and ubiquitin‐aggregation pathology in skeletal muscle

M. Türk,G. Haaker,L. Winter,W. Just,F. Nickel,R. Linker,F. Chevessier,R. Schröder

DOI: https://doi.org/10.1002/mus.24283

2014-09-01

Abstract:A pathological GGGGCC-hexanucleotide-repeat-expansion in the C9ORF72-gene has been described to underlie several neurodegenerative diseases. It has been found to be the most frequent genetic cause of sporadic and familial amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD). Several pathogenic mechanisms have been suggested, including haploinsufficiency, abnormal sequestering of RNA-binding proteins by nuclear GGGGCC-repeat RNA-foci, and pathological dipeptiderepeat proteins derived from non–ATG-initiated translation from the expanded GGGGCC-repeat of the C9ORF72-gene. We report a 59-year-old German man with the rare co-occurrence of C9ORF72-ALS and systemic sarcoidosis. In January 2010, he presented initially with a 2-month history of myalgias and progressive muscle weakness affecting the distal legs. A brother died at age 59 due to bulbar ALS, and his mother, who suffered from progressive dementia, died at age 62. Key findings of his initial neurological work-up included atrophic paresis of distal legs, generalized fasciculations, attenuated ankle reflexes, slightly elevated serum creatine kinase levels, electromyographic evidence of acute and chronic denervation in tibialis anterior and gastrocnemius muscles, and prolonged central motor conduction times to the lower extremities. A familial ALS-FTD-syndrome was suspected. Because of rapid clinical deterioration and a diagnosis of cutaneous sarcoidosis in May 2010, he was reevaluated. In June 2010, a diagnosis of systemic sarcoidosis was made on the basis of mediastinal lymphadenopathy, bronchoalveolar lavage fluid lymphocytosis, and a diagnostic biopsy of the gastrocnemius muscle. In addition to typical sarcoid granulomata, the muscle biopsy showed mild neurogenic changes (Fig. 1A). Because a contribution of muscular or neuronal sarcoidosis to the development of atrophic muscle weakness could not be ruled out, immunosuppressive therapy was initiated, but it was stopped in February 2012 when a second biopsy showed marked neurogenic changes but no evidence of active sarcoidosis (Fig. 1B). At the same time, genetic analysis revealed a pathological hexanucleotide-repeat expansion of more than 600 repeats in C9ORF72. In July 2012, the patient died of respiratory failure. We investigated both muscle biopsies with regard to putative C9ORF72-, p62-, ubiquitin-, and TDP43-pathology. Immunoblot analysis of total muscle protein extracts from both biopsies showed a reduction of the long 54-kDa C9ORF72-isoform (Fig. 1E), which is in keeping with the hypothesis that C9ORF72-pathogenesis is due to haploinsufficiency. Indirect immunofluorescence analysis showed several muscle fibers with p62and ubiquitin-positive cytoplasmic aggregates (Fig. 1C,D), whereas TDP-43 staining did not show any overt pathology. These findings were also mirrored in immunoblots, which revealed increased levels of p62 and ubiquitinated proteins in both muscle biopsies compared with normal muscle controls and a case of muscle sarcoidosis with neurogenic changes (Fig. 1E). These findings indicate that the muscular cytoplasmic inclusions mirror the pathognomonic p62-positive, TDP43-negative neuronal cytoplasmic inclusions which have been found in the cerebral cortex, basal ganglia, hippocampus, and cerebellum of C9ORF72-ALS patients. With regard to the diagnosis and pathogenesis of the disorder, analysis of haploinsufficiency and protein aggregation pathology in skeletal muscle tissue from additional patients with pathological hexanucleotide-repeat-expansion of the C9ORF72-gene is warranted.